Intranasal Vaccines

Feline UltraNasal Vaccines

Heska's Feline UltraNasal Vaccines provide safe, needle-free protection against the most prevalent causes of feline upper respiratory disease and panleukopenia. Heska's Feline UltraNasal Vaccines provide rapid immunity in both cats and kittens with a single 0.2-ml dose and without the risk of injection site sarcoma.

• Laboratory studies demonstrate Feline UltraNasal ® Vaccines provide effective immunity against feline rhinotracheitis virus, feline calicivirus and panleukopenia virus.
• The safety of the vaccines also was tested. The most common clinical sign observed was transient sneezing. Vaccinated cats recovered without incident.
• FVRCP vaccines administered subcutaneously induce a statistically signifcant antibody response against kidney cells. The intranasally administered Feline UltraNasal® Vaccines do not.  Currently, the relationship between these antibodies and feline kidney disease is not known and is the subject of ongoing research.

• To immunize cats against upper respiratory disease, a 0.2-mL dose of Heska’s FVRC vaccine may be administered to kittens as young as 12 weeks of age to provide protective immunity against feline rhinotracheitis and feline calicivirus.
• For protection against upper respiratory disease and panleukopenia virus, a 0.2-mL dose of Heska’s FVRCP vaccine may be administered to cats 12 weeks of age or older. If cats are vaccinated at less than 12 weeks of age, a second vaccination should be administered at 12–16 weeks of age. Annual re-vaccination is recommended.
• When compared to unvaccinated control cats, vaccinated cats had evidence suggesting early protection against virulent herpesvirus-1 challenge as early as two days post-vaccination with signifcant protection being detected by four days post-vaccination. Data generated in another study suggested vaccination of previously uninfected cats via the intranasal route may prevent the subsequent development of a rhinotracheitis virus carrier state following challenge with virulent feld virus, at least in the short term.